Yahoo
NasdaqCM - BOATS Real Time Price USD

Nexentis Technologies Inc. (NXTS)

5.93 +0.12 (+2.07%)
At close: June 24 at 4:00:00 PM EDT
5.93 0.00 (0.00%)
Overnight: 10:46:27 PM EDT
Chart Range Bar
Loading chart for NXTS
Chart does not reflect overnight price.
  • Previous Close 5.81
  • Open 5.90
  • Bid 6.30 x 400
  • Ask 6.28 x 100
  • Day's Range 5.55 - 6.43
  • 52 Week Range 3.38 - 89.92
  • Volume 1,074,212
  • Avg. Volume 1,266,639
  • Market Cap (intraday) 8.618M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -17.51
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

www.nexentistech.com

7

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NXTS
49.57%
S&P 500 (^GSPC)
7.49%

1-Year Return

NXTS
90.16%
S&P 500 (^GSPC)
20.78%

3-Year Return

NXTS
99.41%
S&P 500 (^GSPC)
69.22%

5-Year Return

NXTS
99.96%
S&P 500 (^GSPC)
72.47%

Statistics

View More

Valuation Measures

Annual
As of 6/23/2026
  • Market Cap

    4.32M

  • Enterprise Value

    -1.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.32

  • Price/Book (mrq)

    0.33

  • Enterprise Value/Revenue

    4.18

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -37.56%

  • Return on Equity (ttm)

    -119.61%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -9.81M

  • Diluted EPS (ttm)

    -17.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.2M

  • Total Debt/Equity (mrq)

    3.68%

  • Levered Free Cash Flow (ttm)

    -2.55M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

5.93 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: